Literature DB >> 15978063

N-acetyltransferase is not the rate-limiting enzyme of melatonin synthesis at night.

Tiecheng Liu1, Jimo Borjigin.   

Abstract

Circadian melatonin production in the pineal gland and retina is under the control of serotonin N-acetyltransferase (NAT) and hydroxyindole-O-methyltransferase. Because NAT activity varies diurnally, it has been considered both the melatonin rhythm-generating enzyme and the rate-limiting enzyme of melatonin synthesis. In rats with dramatically reduced NAT activity due to a H28Y mutation in NAT, melatonin levels remained the same as in wildtype controls, suggesting that NAT does not determine the rate of melatonin production at night. Using a combination of molecular approaches with a sensitive in vivo measurement of pineal diurnal melatonin production, we demonstrate that (i) N-acetylserotonin (NAS), the enzymatic product of NAT, is present in vast excess in the night pineals compared with melatonin; (ii) the continuous increase in NAT protein levels at late night does not produce a proportional increase in melatonin; and (iii) an increase in NAS in the same animal over several circadian cycles do not result in corresponding increase in melatonin output. These results strongly suggest that NAT is not the rate-limiting enzyme of melatonin formation at night.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978063     DOI: 10.1111/j.1600-079X.2005.00223.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  36 in total

Review 1.  Melatonin membrane receptors in peripheral tissues: distribution and functions.

Authors:  Radomir M Slominski; Russel J Reiter; Natalia Schlabritz-Loutsevitch; Rennolds S Ostrom; Andrzej T Slominski
Journal:  Mol Cell Endocrinol       Date:  2012-01-08       Impact factor: 4.102

Review 2.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

3.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 4.  Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology.

Authors:  Neeraj Joshi; Joyshree Biswas; C Nath; Sarika Singh
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

Review 5.  Application of long-term microdialysis in circadian rhythm research.

Authors:  Jimo Borjigin; Tiecheng Liu
Journal:  Pharmacol Biochem Behav       Date:  2007-10-25       Impact factor: 3.533

Review 6.  Seasonal Reproduction in Vertebrates: Melatonin Synthesis, Binding, and Functionality Using Tinbergen's Four Questions.

Authors:  Dax viviD; George E Bentley
Journal:  Molecules       Date:  2018-03-13       Impact factor: 4.411

Review 7.  Melatonin formation in mammals: in vivo perspectives.

Authors:  Asamanja Chattoraj; Tiecheng Liu; Liang Samantha Zhang; Zheping Huang; Jimo Borjigin
Journal:  Rev Endocr Metab Disord       Date:  2009-12       Impact factor: 6.514

8.  Therapeutic actions of melatonin on gastrointestinal cancer development and progression.

Authors:  Rachael Glenister; Kelly McDaniel; Heather Francis; Julie Venter; Kendal Jensen; Giuseppina Dusio; Eugenio Gaudio; Shannon Glaser; Fanyin Meng; Gianfranco Alpini
Journal:  Transl Gastrointest Cancer       Date:  2013-01-01

9.  Posttranscriptional regulation of pineal melatonin synthesis in Octodon degus.

Authors:  Soo Jung Lee; Tiecheng Liu; Asamanja Chattoraj; Samantha L Zhang; Lijun Wang; Theresa M Lee; Michael M Wang; Jimo Borjigin
Journal:  J Pineal Res       Date:  2009-06-17       Impact factor: 13.007

Review 10.  Role of the melatonin system in the control of sleep: therapeutic implications.

Authors:  Seithikurippu R Pandi-Perumal; Venkatramanujan Srinivasan; D Warren Spence; Daniel P Cardinali
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.